BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2023 Earnings Conference Call May 3, 2023 8:30 AM ET Company Participants John Bluth - Investor Relations Jon Stonehouse - Chief Executive Officer Anthony Doyle - Chief Financial Officer Charlie Gayer - Chief Commercial Officer Helen Thackray - Chief R&D Officer Conference Call Participants Allison Bratzel - Piper Sandler Jon Wolleben - JMP Securities Tazeen Ahmad - Bank of America Stacy Ku - Cowen & Co. Justin Kim - Oppenheimer & Co. Inc. Serge Belanger - Nee ...